Medasense Press Releases

• Published on December 12, 2024 - 08:00 GMT

  

  Medtronic Israel Partners with Medasense to Distribute the NOL Nociception Monitoring Technology

  Medasense has announced a strategic agreement with Medtronic Israel to distribute its PMD-200 patient monitoring device with NOL® technology in Israel. RAMAT GAN, ISRAEL, December 12, 2024 /⁨EINPresswire.com⁩/ -- Medasense, a pioneer in pain monitoring …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on September 12, 2024 - 12:00 GMT

  Medasense Selected to Exhibit the NOL – Nociception Level Index Technology at Vizient Innovative Technology Exchange

  Medasense will showcase its AI-powered NOL technology at Vizient's Innovative Technology Exchange, revolutionizing pain monitoring for improved patient care. BETHLEHEM, PA, UNITED STATES, September 12, 2024 /⁨EINPresswire.com⁩/ -- Medasense Biometrics …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on July 23, 2024 - 11:00 GMT

  

  New Study from Japan Shows NOL-Guided Analgesia Reduces Intraoperative Opioids & Improves Pain up to 3 Days Post-Surgery

  Study has found that monitoring pain levels during surgery with NOL can help reduce intraoperative opioid usage and postop pain up to 3 days after surgery. RAMAT GAN, ISRAEL, July 23, 2024 /⁨EINPresswire.com⁩/ -- A new study has found that monitoring pain …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on June 4, 2024 - 11:13 GMT

  

  Panakeia, LLC Partners with Medasense to Distribute 1st FDA authorized Nociception Monitor in US Government Institutions

  Medasense has reached a strategic agreement with Panakeia to distribute Medasense's PMD-200 device to United States government institutions. RAMAT GAN, ISRAEL, June 4, 2024 /⁨EINPresswire.com⁩/ -- Medasense, a pioneer in pain monitoring technology, …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on January 4, 2022 - 15:15 GMT

  Study Explores the Ability of NOL Technology to Detect Pain in the ICU

  A peer-reviewed observational study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients. RAMAT GAN, ISRAEL, January 4, 2022 /⁨EINPresswire.com⁩/ -- The peer-reviewed journal Journal of …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...